HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Digital Solutions to Diagnose and Manage Postbariatric Hypoglycemia.

Abstract
Postbariatric hypoglycemia (PBH) is an increasingly recognized late metabolic complication of bariatric surgery, characterized by low blood glucose levels 1-3 h after a meal, particularly if the meal contains rapid-acting carbohydrates. PBH can often be effectively managed through appropriate nutritional measures, which remain the cornerstone treatment today. However, their implementation in daily life continues to challenge both patients and health care providers. Emerging digital technologies may allow for more informed and improved decision-making through better access to relevant data to manage glucose levels in PBH. Examples include applications for automated food analysis from meal images, digital receipts of purchased food items or integrated platforms allowing the connection of continuously measured glucose with food and other health-related data. The resulting multi-dimensional data can be processed with artificial intelligence systems to develop prediction algorithms and decision support systems with the aim of improving glucose control, safety, and quality of life of PBH patients. Digital innovations, however, face trade-offs between user burden vs. amount and quality of data. Further challenges to their development are regulatory non-compliance regarding data ownership of the platforms acquiring the required data, as well as user privacy concerns and compliance with regulatory requirements. Through navigating these trade-offs, digital solutions could significantly contribute to improving the management of PBH.
AuthorsKatja A Schönenberger, Luca Cossu, Francesco Prendin, Giacomo Cappon, Jing Wu, Klaus L Fuchs, Simon Mayer, David Herzig, Andrea Facchinetti, Lia Bally
JournalFrontiers in nutrition (Front Nutr) Vol. 9 Pg. 855223 ( 2022) ISSN: 2296-861X [Print] Switzerland
PMID35464035 (Publication Type: Journal Article, Review)
CopyrightCopyright © 2022 Schönenberger, Cossu, Prendin, Cappon, Wu, Fuchs, Mayer, Herzig, Facchinetti and Bally.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: